$1.61 EPS Expected for CVS Health Corporation (CVS)

July 14, 2018 - By Elena Maslow

CVS Health Corporation (NYSE:CVS) LogoInvestors sentiment increased to 0.9 in 2018 Q1. Its up 0.18, from 0.72 in 2017Q4. It increased, as 97 investors sold CVS Health Corporation shares while 512 reduced holdings. 117 funds opened positions while 431 raised stakes. 821.03 million shares or 0.67% more from 815.59 million shares in 2017Q4 were reported.
Brown Brothers Harriman And invested in 0.01% or 37,113 shares. Renaissance Ltd Limited Liability Company holds 1.92M shares. Westpac Corporation stated it has 0% of its portfolio in CVS Health Corporation (NYSE:CVS). Bradley Foster And Sargent Ct reported 26,477 shares or 0.06% of all its holdings. Georgia-based Asset Advsr has invested 0.08% in CVS Health Corporation (NYSE:CVS). Wealth Enhancement Advisory Limited stated it has 24,063 shares. Country Club Na holds 79,017 shares or 0.6% of its portfolio. Atlantic Trust Group Ltd Liability, Georgia-based fund reported 1.22 million shares. Levin Cap Strategies Ltd Partnership reported 8,110 shares. Regent Limited Liability Corp reported 68,939 shares or 1.45% of all its holdings. Naples Advsrs Lc owns 7,835 shares for 0.14% of their portfolio. Caprock has invested 0.18% of its portfolio in CVS Health Corporation (NYSE:CVS). Rand Wealth Limited Liability Company holds 0.24% of its portfolio in CVS Health Corporation (NYSE:CVS) for 34,778 shares. Rmb Capital Mgmt Llc stated it has 6,809 shares or 0.01% of all its holdings. Intrust Fincl Bank Na, Kansas-based fund reported 9,411 shares.

Since February 16, 2018, it had 2 insider buys, and 1 insider sale for $713,454 activity. Another trade for 19,965 shares valued at $1.42M was sold by Foulkes Helena. 24,300 CVS Health Corporation (NYSE:CVS) shares with value of $1.51M were bought by DORMAN DAVID W.

Analysts expect CVS Health Corporation (NYSE:CVS) to report $1.61 EPS on August, 14.They anticipate $0.28 EPS change or 21.05 % from last quarter’s $1.33 EPS. CVS’s profit would be $1.64B giving it 10.66 P/E if the $1.61 EPS is correct. After having $1.48 EPS previously, CVS Health Corporation’s analysts see 8.78 % EPS growth. The stock increased 0.94% or $0.64 during the last trading session, reaching $68.63. About 5.59M shares traded. CVS Health Corporation (NYSE:CVS) has declined 13.06% since July 14, 2017 and is downtrending. It has underperformed by 25.63% the S&P500.

CVS Health Corporation (NYSE:CVS) Ratings Coverage

Among 10 analysts covering CVS Health (NYSE:CVS), 9 have Buy rating, 0 Sell and 1 Hold. Therefore 90% are positive. CVS Health had 14 analyst reports since January 17, 2018 according to SRatingsIntel. The stock of CVS Health Corporation (NYSE:CVS) earned “Buy” rating by RBC Capital Markets on Thursday, February 8. Morgan Stanley maintained CVS Health Corporation (NYSE:CVS) rating on Tuesday, July 3. Morgan Stanley has “Overweight” rating and $80 target. The firm has “Buy” rating by Needham given on Tuesday, January 30. The firm has “Buy” rating by Mizuho given on Wednesday, January 24. The firm earned “Buy” rating on Wednesday, April 11 by Bank of America. The company was maintained on Wednesday, January 17 by Robert W. Baird. The firm has “Buy” rating by SunTrust given on Tuesday, April 17. As per Tuesday, April 10, the company rating was maintained by Leerink Swann. The stock of CVS Health Corporation (NYSE:CVS) earned “Outperform” rating by Leerink Swann on Friday, February 9. The stock of CVS Health Corporation (NYSE:CVS) has “Hold” rating given on Thursday, February 8 by Robert W. Baird.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. The company has market cap of $69.77 billion. It operates through Pharmacy Services and Retail/LTC divisions. It has a 10.52 P/E ratio. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Seekingalpha.com which released: “CVS And Aetna Are Changing The Healthcare Paradigm” on June 18, 2018, also Seekingalpha.com with their article: “Walgreens And CVS: DEFCON Amazon” published on July 05, 2018, Seekingalpha.com published: “CVS: Downright Undervalued And A Great Pick For Your Portfolio” on June 28, 2018. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Seekingalpha.com and their article: “CVS Health: Surviving Amazon” published on June 25, 2018 as well as Fool.com‘s news article titled: “Why CVS Health Corp., Rite Aid Corporation, and Walgreens Boots Alliance Inc. Stocks Tanked Today” with publication date: June 28, 2018.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.